Semen Analysis After Proton Therapy for Prostate Cancer

Semen Analysis Following Definitive Treatment of Prostate Cancer With Proton Radiation Therapy Alone

The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.

Inclusion Criteria:

- Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI).

Exclusion Criteria:

• Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.
• History of vasectomy.
• Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.
• Current use of Avodart or Proscar.